Why Is CELLEBRITE DI LTD A (CLBT) Stock Down Today?

Cellebrite DI Ltd (CLBT) closed down 6.28% at $10.44 on August 18, 2026, driven by a combination of weak revenue guidance and multiple securities investigations. The stock has fallen 29.3% over the last eight sessions amid ongoing investor concern. Recent developments include a downward revision of full-year revenue expectations and the initiation of multiple investigations into potential securities law violations.

What Happened

Cellebrite cut its full-year 2026 revenue guidance to a range of $555 million to $561 million from the previous $565 million to $571 million. The company also lowered its Q3 revenue forecast to between $145 million and $148 million, below the $150.3 million consensus estimate. While Q2 adjusted earnings per share met expectations at 11 cents, the downward guidance triggered a sharp sell-off.

On the same day, two separate investigations were announced. Block & Leviton and Kaplan Fox & Kilsheimer LLP are looking into potential securities law violations by Cellebrite. These investigations add to legal and reputational risk for the company. Additionally, the CEO and other senior executives sold shares on August 12, 2026, according to SEC filings. Retail traders on Reddit have raised concerns about whether these sales might be linked to insider knowledge.

What The Data Shows

The stock has traded down 29.3% over the last eight sessions, from $15.64 to $11.06. The recent drop has pushed CLBT closer to its 52-week low of $9.58, with the stock having printed 25 fresh 52-week lows on August 18. The company has a market cap of $3.9 billion and a P/E ratio of 45.0. Despite revenue growth of 18.4% in the trailing twelve months, the stock’s beta of 1.18 suggests it remains more volatile than the broader market. Over the last 90 days, insiders have sold a total of $4.5 million worth of shares, with no insider purchases recorded.

What To Watch

Cellebrite’s stock will remain under pressure until the ongoing investigations are resolved or new guidance is provided. Investors should monitor the company’s next earnings report for further clarity on its financial outlook and any updates on the legal proceedings.